Table 1.
CDC MIS-C case definition [5] | WHO MIS-C case definition [6] | RCPCH PIMS-TS case definition [7] | CDC MIS-A case definition [8] | ||
---|---|---|---|---|---|
Age | < 21 years old | 0–19 years old | Child (unspecified age) | Patient demographics | ≥ 21 years old + hospitalized for ≥ 24 h OR with illness resulting in death |
Fever | Fever ≥ 38.5 °C (or subjective fever) for ≥ 24 h | Fever ≥ 3 days (unspecified degree) | Persistent fever (unspecified degree) | Fever | Subjective or documented fever ≥ 38.5 °C for ≥ 24 h prior to and/or within the first 3 days of hospitalization |
Inflammation |
Laboratory evidence of inflammation - One or more of the following: elevated CRP, ESR, fibrinogen, procalcitonin, d-dimer, ferritin, LDH, or IL-6, elevated neutrophils, reduced lymphocytes, and low albumin |
Elevated markers of inflammation - ESR, CRP, procalcitonin |
Inflammation - neutrophilia, elevated CRP, and lymphopenia |
Requires 3 of the following clinical criteria (one must be a primary clinical criterion), evidence of inflammation, and SARS-CoV-2 infection: | |
System involvement | Clinically severe illness requiring hospitalization with ≥ 2 organ systems involved |
Two of the following: - Rash or bilateral conjunctivitis or mucocutaneous inflammation - Hypotension or shock - Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities via echocardiography findings or elevated cardiac enzymes - Evidence of coagulopathy by PT, PTT, elevated d-dimers - Acute gastrointestinal problems—diarrhea, vomiting, abdominal pain |
Single or multi-organ dysfunction: - Shock, cardiac, respiratory, renal, gastrointestinal, or neurological disorder - May include children fulfilling full or partial KD criteria - “Additional features”—broad list of symptoms, lab findings, and imaging in appendix of criteria |
Primary criteria |
- Severe cardiac illness: myocarditis, pericarditis, coronary artery changes, or new-onset RV/LV dysfunction, 2nd/3rd degree AV block, or ventricular tachycardia - Rash and non-purulent conjunctivitis |
Rule-out of additional causes | No alternative plausible diagnosis |
No other obvious microbial cause of inflammation - Rule-out bacterial sepsis, staph, or strep shock syndromes |
Exclusion of other microbial causes - Bacterial sepsis, staph/strep shock syndromes, viral myocarditis-related infections |
Secondary criteria |
- New-onset neurologic signs or symptoms: encephalopathy, seizures, meningeal signs, peripheral neuropathy - Shock or hypotension - Abdominal pain, vomiting, or diarrhea - Platelet count < 150,000/microliter |
COVID-19 link | Current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or exposure to suspected or confirmed COVID-19 case within 4 weeks | Evidence of COVID-19 (RT-PCR, antigen test, serology positive), or likely contact with COVID-19 patient | Positive or negative SARS-CoV-2 PCR testing | Laboratory evidence |
- Elevation of two of the following: CRP, ferritin, ESR, IL-6 level, and procalcitonin - Positive SARS-CoV-2 test via RT-PCR, serology, or antigen |
RT-PCR, reverse transcription-polymerase chain reaction; PT, pro-thrombin time; PTT, partial thromboplastin time; ESR, erythrocyte sedimentation rate; CRP, c-reactive protein; IL-6, interleukin-6; RV, right ventricle; LV, left ventricle; AV, atrioventricular